177 related articles for article (PubMed ID: 20044910)
1. Hexosomes: a novel drug delivery system.
Hirlekar R; Jain S; Patel M; Garse H; Kadam V
Curr Drug Deliv; 2010 Jan; 7(1):28-35. PubMed ID: 20044910
[TBL] [Abstract][Full Text] [Related]
2. Cubic phase gels as drug delivery systems.
Shah JC; Sadhale Y; Chilukuri DM
Adv Drug Deliv Rev; 2001 Apr; 47(2-3):229-50. PubMed ID: 11311994
[TBL] [Abstract][Full Text] [Related]
3. Enhanced oromucosal delivery of progesterone via hexosomes.
Swarnakar NK; Jain V; Dubey V; Mishra D; Jain NK
Pharm Res; 2007 Dec; 24(12):2223-30. PubMed ID: 17828445
[TBL] [Abstract][Full Text] [Related]
4. Oral and transdermal drug delivery systems: role of lipid-based lyotropic liquid crystals.
Rajabalaya R; Musa MN; Kifli N; David SR
Drug Des Devel Ther; 2017; 11():393-406. PubMed ID: 28243062
[TBL] [Abstract][Full Text] [Related]
5. Lyotropic liquid crystalline phases: Drug delivery and biomedical applications.
Chavda VP; Dyawanapelly S; Dawre S; Ferreira-Faria I; Bezbaruah R; Rani Gogoi N; Kolimi P; Dave DJ; Paiva-Santos AC; Vora LK
Int J Pharm; 2023 Nov; 647():123546. PubMed ID: 37884213
[TBL] [Abstract][Full Text] [Related]
6. New lipid family that forms inverted cubic phases in equilibrium with excess water: molecular structure-aqueous phase structure relationship for lipids with 5,9,13,17-tetramethyloctadecyl and 5,9,13,17-tetramethyloctadecanoyl chains.
Yamashita J; Shiono M; Hato M
J Phys Chem B; 2008 Oct; 112(39):12286-96. PubMed ID: 18774852
[TBL] [Abstract][Full Text] [Related]
7. Soft matter dispersions with ordered inner structures, stabilized by ethoxylated phytosterols.
Libster D; Aserin A; Yariv D; Shoham G; Garti N
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):202-15. PubMed ID: 19682869
[TBL] [Abstract][Full Text] [Related]
8. Tacrolimus-loaded nanostructured lipid carriers for oral delivery - Optimization of production and characterization.
Khan S; Shaharyar M; Fazil M; Baboota S; Ali J
Eur J Pharm Biopharm; 2016 Nov; 108():277-288. PubMed ID: 27449630
[TBL] [Abstract][Full Text] [Related]
9. Physicochemical characterization and thermal behavior of hexosomes containing ketoconazole as potential topical antifungal delivery system.
Gazga-Urioste C; Rivera-Becerril E; Pérez-Hernández G; Angélica Noguez-Méndez N; Faustino-Vega A; Tomás Quirino-Barreda C
Drug Dev Ind Pharm; 2019 Jan; 45(1):168-176. PubMed ID: 30231655
[TBL] [Abstract][Full Text] [Related]
10. Lipid polymorphism in lyotropic liquid crystals for triggered release of bioactives.
Garti N; Libster D; Aserin A
Food Funct; 2012 Jul; 3(7):700-13. PubMed ID: 22592749
[TBL] [Abstract][Full Text] [Related]
11. Development of clinical dosage forms for a poorly water-soluble drug II: formulation and characterization of a novel solid microemulsion preconcentrate system for oral delivery of a poorly water-soluble drug.
Li P; Hynes SR; Haefele TF; Pudipeddi M; Royce AE; Serajuddin AT
J Pharm Sci; 2009 May; 98(5):1750-64. PubMed ID: 18781639
[TBL] [Abstract][Full Text] [Related]
12. Bulk and dispersed aqueous behaviour of an endogenous lipid, selachyl alcohol: Effect of Tween 80 and Pluronic F127 on nanostructure.
Younus M; Hawley A; Boyd BJ; Rizwan SB
Colloids Surf B Biointerfaces; 2018 Sep; 169():135-142. PubMed ID: 29758539
[TBL] [Abstract][Full Text] [Related]
13. Bioimaging Applications of Non-Lamellar Liquid Crystalline Nanoparticles.
Murgia S; Biffi S; Fornasier M; Lippolis V; Picci G; Caltagirone C
J Nanosci Nanotechnol; 2021 May; 21(5):2742-2759. PubMed ID: 33653441
[TBL] [Abstract][Full Text] [Related]
14. Recent Advances in the Development of Liquid Crystalline Nanoparticles as Drug Delivery Systems.
Leu JSL; Teoh JJX; Ling ALQ; Chong J; Loo YS; Mat Azmi ID; Zahid NI; Bose RJC; Madheswaran T
Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242663
[TBL] [Abstract][Full Text] [Related]
15. Hexosomes formed from glycerate surfactants--formulation as a colloidal carrier for irinotecan.
Boyd BJ; Whittaker DV; Khoo SM; Davey G
Int J Pharm; 2006 Aug; 318(1-2):154-62. PubMed ID: 16621358
[TBL] [Abstract][Full Text] [Related]
16. [Advances in the study of lipid-based cubic liquid crystalline nanoparticles as drug delivery system].
Wu HB; Huo DF; Jiang XG
Yao Xue Xue Bao; 2008 May; 43(5):450-5. PubMed ID: 18717329
[TBL] [Abstract][Full Text] [Related]
17. Inverted micellar intermediates and the transitions between lamellar, cubic, and inverted hexagonal amphiphile phases. III. Isotropic and inverted cubic state formation via intermediates in transitions between L alpha and HII phases.
Siegel DP
Chem Phys Lipids; 1986 Dec; 42(4):279-301. PubMed ID: 3829210
[TBL] [Abstract][Full Text] [Related]
18. Lyotropic Liquid Crystalline Nanostructures as Drug Delivery Systems and Vaccine Platforms.
Chountoulesi M; Pispas S; Tseti IK; Demetzos C
Pharmaceuticals (Basel); 2022 Mar; 15(4):. PubMed ID: 35455426
[TBL] [Abstract][Full Text] [Related]
19. Self-assembled multicompartment liquid crystalline lipid carriers for protein, peptide, and nucleic acid drug delivery.
Angelova A; Angelov B; Mutafchieva R; Lesieur S; Couvreur P
Acc Chem Res; 2011 Feb; 44(2):147-56. PubMed ID: 21189042
[TBL] [Abstract][Full Text] [Related]
20. The physical properties of glycosyl diacylglycerols. Calorimetric, X-ray diffraction and Fourier transform spectroscopic studies of a homologous series of 1,2-di-O-acyl-3-O-(beta-D-galactopyranosyl)-sn-glycerols.
Mannock DA; Harper PE; Gruner SM; McElhaney RN
Chem Phys Lipids; 2001 Jun; 111(2):139-61. PubMed ID: 11457442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
